Lifecore Biomedical (LFCR) vs Sol-Gel Technologies (SLGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sol-Gel Technologies (SLGL) has outperformed Lifecore Biomedical (LFCR) over the past year, gaining 75.5% versus a loss of 4.5%. Over five years, SLGL leads with a -22.8% price change compared with -34.4% for LFCR. Lifecore Biomedical is the larger company by market cap ($244.1 million vs $235.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFCR | SLGL |
|---|---|---|
| Share price | $6.44 | $71.95 |
| Market cap | $244.11M | $235.55M |
| 1-day change | -0.16% | -4.88% |
| YTD return | -21.27% | +70.73% |
| 1-year return | -4.45% | +75.52% |
| 5-year return | -34.35% | -22.85% |
| EPS (TTM) | $-1.27 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.98 | $97.97 |
| 52-week low | $3.63 | $28.81 |
| Distance from 52-week high | -28.29% | -26.56% |
| Average volume | 264.01K | 55.68K |
| Shares outstanding | 37.91M | 3.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SLGL has outperformed LFCR by 80.0 percentage points over the past year.
LFCR vs SLGL FAQ
Which is bigger, Lifecore Biomedical or Sol-Gel Technologies?
Lifecore Biomedical (LFCR) is larger, with a market capitalization of $244.11M compared with $235.55M for Sol-Gel Technologies (SLGL).
Which stock has performed better over the past year, LFCR or SLGL?
SLGL returned +75.52% over the past 12 months, compared with -4.45% for LFCR (price return, excluding dividends). Past performance does not predict future results.
Are Lifecore Biomedical and Sol-Gel Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.